ENZYMES AND CANCER

 

Enzymes digest cancer cells

PANCREATIC ENZYMES

Pancreatic enzymes form the first layer of defense the body has against cancer. The pancreas secretes digestive enzymes which assist the bodies natural defenses against cancer cells.

The cancer cell is coated and protected by a protein lining (or covering). When this protein covering is removed it leaves the cancer cell exposed and the body's natural defense Leukocytes (white blood cells) comes into effect killing the cancer cells. If the body is unable to penetrate and break down the protein coating of the cancer cell then the cells will multiply and spread (Metastasise) around the body and various tumours will form as body attempts to isolate the cells from spreading. 

Therefore it is extremely important we understand the role of these digestive enzymes in the body. Two enzymes in particular which are secreted by the pancreas are Trypsin and Chymotrypsin. These two enzymes have been found to dissolve the protein coating of the cancer cell allowing the body's defences to kill the cancer cells.

So it stands to reason that if we use up the bodies reserves of these two enzymes we will be left defenseless against cancer cells attacking our body. So it makes sense to supply the body with further digestive enzymes (or proteolytic enzymes) which eat away at the protein shell of the cancer cell. Like wise it stands to reason to eliminate any practices that may use up our reserves of these digestive enzymes..........

The last stage of digestion, is probably the most significant for cancer patients. In this stage pancreatic and other enzymes are functioning in the intestine and the blood. Taking supplements takes the load off of the body’s need to expend energy to produce the enzymes itself, according to Dr. Hector Solorzano, M.D., Coordinator of the Program for Studies of Alternative Medicine and Professor of Pharmacology of the University of Guadalajara in Mexico. He reports:

  • enzymes help expose antigens on the surface of cancer cells, so they can be recognized as foreign and destroyed by the immune system.

  • circulating immune complexes (CIC’s), produced when cancerous cells shed their antigens into the circulation to avoid detection by the immune system, can be destroyed by pancreatic enzymes.

  • pancreatic enzymes can stimulate natural killer cells, T-cells, and tumor necrosis factor, all toxic to cancer cells.

  • Finally, Dr. Solorzano reports that by removing the "sticky" coating found on tumor cells, enzymes reduce the risk of tumors adhering to other areas of the body and allow the enzyme to enter the cancer cell during it’s reproductive phase. Vitamin A increases this effect. (note: the emphasis is mine. If these points are true, then this is very important to cancer battlers.

A study published in the journal Pancreas suggests the effectiveness of pancreatic enzymes against cancer in mice. This form of nutritional cancer therapy has been used by Nicholas Gonzalez, M.D. in his medical practice in New York City. Gonzalez is one of the authors of the study, "Pancreatic Enzyme Extract Improves Survival in Murine Pancreatic Cancer" (Pancreas. 2004 May;28(4):401-12).

The study found that mice treated with pancreatic enzymes survived significantly longer than the control group. Tumors growth in the enzyme-treated group was significantly slowed compared to the control group.

In addition, while all mice in the control group showed the conditions steatorrhea, high glucose in the urine, high levels of bilirubin, and ketones in the urine at the early stages of tumor growth, only a few in the treated group showed some of these abnormalities at the final stage.

Five years ago, a pilot study of human cancer patients treated by Gonzalez and his associate was published in in the journal Nutrition and Cancer. From there, Gonzalez received a $1.4 million federal grant for a Phase III prospective clinical trial of people with pancreatic cancer. This multi-year study is ongoing.

This enzyme-based cancer treatment has been written about for nearly a century. In an article that appeared in the British Medical Journal in 1906, embyologist John Beard wrote that pancreatic enzymes are one of the body's defenses against cancer and would be useful as a cancer treatment. He later wrote a book entitled The Enzyme Treatment of Cancer A dentist names William Donald Kelley later expanded on this treatment.

The results of this study are promising because pancreatic cancer is difficult to treat and has a high mortality rate, due to difficulties in diagnosis, the aggressive nature of pancreatic cancer, and the few treatment options available. Pancreatic cancer is the fifth leading cause of cancer deaths following breast cancer, lung cancer, colon cancer, and prostate cancer.